Assessment of a Wearable Ultrafiltration Device

Launched by LONDON HEALTH SCIENCES CENTRE RESEARCH INSTITUTE OR LAWSON RESEARCH INSTITUTE OF ST. JOSEPH'S · Feb 12, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new wearable device designed to help patients with kidney failure who are undergoing dialysis. Dialysis is a treatment that cleans waste products from the blood, but it can be tough on the body, leading to complications and discomfort, especially when too much fluid is removed quickly. The new device aims to gently remove extra fluid from the body between dialysis sessions, which could help patients feel better and potentially live longer by reducing harm to their organs.

To participate in this trial, candidates must be at least 18 years old and currently on dialysis three times a week. They should have trouble removing enough fluid during their regular treatments or need extra help to reach a healthy weight. However, individuals with active infections or those who do not follow their dialysis schedule cannot join. Participants in the study will have the chance to use this innovative device and contribute to important research that could change the way dialysis patients manage fluid levels and improve their overall health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * At least one of the following:
• • 1. Average per-session IDWG ≥ 4.0% of dry weight in the last month
• • 2. Inability to consistently achieve dry weight with current HD
• • 3. Need for additional HD treatments to achieve prescribed dry weight
• • HD sessions three times/week
• • Age ≥ 18 years
• • Dialyzing via central venous access
• • Willing and able to provide informed consent
• Exclusion Criteria:
• • Active infections
• • Non-compliance to hemodialysis prescription/schedule